Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 2
1988 1
1989 1
1993 1
1996 2
1997 1
1998 2
1999 1
2000 1
2001 1
2002 1
2003 1
2004 2
2005 1
2006 3
2007 4
2008 2
2009 2
2010 7
2011 9
2012 9
2013 8
2014 9
2015 6
2016 8
2017 7
2018 9
2019 10
2020 8
2021 12
2022 10
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Arrhythmogenic right ventricular dysplasia 13"
Page 1
Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy.
Roudijk RW, Verheul L, Bosman LP, Bourfiss M, Breur JMPJ, Slieker MG, Blank AC, Dooijes D, van der Heijden JF, van den Heuvel F, Clur SA, Udink Ten Cate FEA, van den Berg MP, Wilde AAM, Asselbergs FW, Peter van Tintelen J, Te Riele ASJM. Roudijk RW, et al. JACC Clin Electrophysiol. 2022 Mar;8(3):306-318. doi: 10.1016/j.jacep.2021.09.001. Epub 2021 Dec 22. JACC Clin Electrophysiol. 2022. PMID: 35331425 Free article.
OBJECTIVES: The goal of this study was to describe characteristics, cascade screening results, and predictors of adverse outcome in pediatric-onset arrhythmogenic right ventricular cardiomyopathy (ARVC). ...Clinical presentation, diagnostic testing, an …
OBJECTIVES: The goal of this study was to describe characteristics, cascade screening results, and predictors of adverse outcome in p …
Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Carrick RT, Te Riele ASJM, Gasperetti A, Bosman L, Muller SA, Pendleton C, Tichnell C, Murray B, Yap SC, van den Berg MP, Wilde A, Zeppenfeld K, Hays A, Zimmerman SL, Tandri H, Cadrin-Tourigny J, van Tintelen P, Calkins H, James CA, Wu KC. Carrick RT, et al. Circ Arrhythm Electrophysiol. 2022 Nov;15(11):e011207. doi: 10.1161/CIRCEP.122.011207. Epub 2022 Oct 31. Circ Arrhythm Electrophysiol. 2022. PMID: 36315818 Free PMC article.
BACKGROUND: The arrhythmogenic right ventricular cardiomyopathy (ARVC) risk calculator stratifies risk for incident sustained ventricular arrhythmias (VA) at the time of ARVC diagnosis. ...Observed risk for VA decreased by 13% by 5 years …
BACKGROUND: The arrhythmogenic right ventricular cardiomyopathy (ARVC) risk calculator stratifies risk for incident sus …
Electrocardiographic features of arrhythmogenic right ventricular cardiomyopathy in school-aged children.
Fujino M, Miyazaki A, Furukawa O, Somura J, Yoshida Y, Hayama Y, Kamakura S, Negishi J, Wada M, Kusano K, Ohuchi H. Fujino M, et al. Heart Vessels. 2021 Jun;36(6):863-873. doi: 10.1007/s00380-020-01754-2. Epub 2021 Jan 29. Heart Vessels. 2021. PMID: 33511492
It can be difficult to distinguish children with early-stage arrhythmogenic right ventricular cardiomyopathy (ARVC) from those with benign premature ventricular contraction (PVC). ...At ARVC diagnosis, the treadmill exercise test and Holter monitoring …
It can be difficult to distinguish children with early-stage arrhythmogenic right ventricular cardiomyopathy (ARVC) fro …
Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy.
Muller SA, Gasperetti A, Bosman LP, Schmidt AF, Baas AF, Amin AS, Houweling AC, Wilde AAM, Compagnucci P, Targetti M, Casella M, Calò L, Tondo C, van der Harst P, Asselbergs FW, van Tintelen JP, Oerlemans MIFJ, Te Riele ASJM. Muller SA, et al. J Am Coll Cardiol. 2023 Jul 18;82(3):214-225. doi: 10.1016/j.jacc.2023.05.005. Epub 2023 May 18. J Am Coll Cardiol. 2023. PMID: 37210036 Free article.
BACKGROUND: Clinical guidelines recommend regular screening for arrhythmogenic right ventricular cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources. ...METHODS: A total of 136 relatives (46% men, median …
BACKGROUND: Clinical guidelines recommend regular screening for arrhythmogenic right ventricular cardiomyopathy (ARVC) …
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
Carrick RT, De Marco C, Gasperetti A, Bosman LP, Gourraud JB, Trancuccio A, Mazzanti A, Murray B, Pendleton C, Tichnell C, Tandri H, Zeppenfeld K, Wilde AAM, Davies B, Seifer C, Roberts JD, Healey JS, MacIntyre C, Alqarawi W, Tadros R, Cutler MJ, Targetti M, Calò L, Vitali F, Bertini M, Compagnucci P, Casella M, Dello Russo A, Cappelletto C, De Luca A, Stolfo D, Duru F, Jensen HK, Svensson A, Dahlberg P, Hasselberg NE, Di Marco A, Jordà P, Arbelo E, Moreno Weidmann Z, Borowiec K, Delinière A, Biernacka EK, van Tintelen JP, Platonov PG, Olivotto I, Saguner AM, Haugaa KH, Cox M, Tondo C, Merlo M, Krahn AD, Te Riele ASJM, Wu KC, Calkins H, James CA, Cadrin-Tourigny J. Carrick RT, et al. Eur Heart J. 2024 Feb 16;45(7):538-548. doi: 10.1093/eurheartj/ehad799. Eur Heart J. 2024. PMID: 38195003 Free PMC article.
BACKGROUND AND AIMS: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmogenic right ventricular cardiomyopathy (ARVC). This study aims to identify cross-continental differences in utilization of p …
BACKGROUND AND AIMS: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmoge …
Pregnancy and newborn outcomes in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Gandjbakhch E, Varlet E, Duthoit G, Fressart V, Charron P, Himbert C, Maupain C, Bordet C, Hidden-Lucet F, Nizard J. Gandjbakhch E, et al. Int J Cardiol. 2018 May 1;258:172-178. doi: 10.1016/j.ijcard.2017.11.067. Int J Cardiol. 2018. PMID: 29544927
INTRODUCTION: The prognosis of pregnancy in patients with Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia (ARVC/D) is poorly documented. ...CONCLUSION: ARVC/D is associated with a low rate of major cardiac events during pregnancy and vaginal …
INTRODUCTION: The prognosis of pregnancy in patients with Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia …
Arrhythmogenic cardiomyopathy and differential diagnosis with physiological right ventricular remodelling in athletes using cardiovascular magnetic resonance.
Moccia E, Papatheodorou E, Miles CJ, Merghani A, Malhotra A, Dhutia H, Bastiaenen R, Sheikh N, Zaidi A, Sanna GD, Homfray T, Bunce N, Anderson LJ, Tome M, Behr E, Moon J, Sharma S, Finocchiaro G, Papadakis M. Moccia E, et al. Int J Cardiovasc Imaging. 2022 Dec;38(12):2723-2732. doi: 10.1007/s10554-022-02684-y. Epub 2022 Jul 21. Int J Cardiovasc Imaging. 2022. PMID: 36445664
To describe the overlap between structural abnormalities typical of arrhythmogenic right ventricular cardiomyopathy (ARVC) and physiological right ventricular adaptation to exercise and differentiate between pathologic and physiologic findings u …
To describe the overlap between structural abnormalities typical of arrhythmogenic right ventricular cardiomyopathy (AR …
Arrhythmogenic Right Ventricular Cardiomyopathy Prevalence and Arrhythmic Outcomes in At-Risk Family Members: A Systematic Review and Meta-Analysis.
Sharma A, Bosman LP, Tichnell C, Nanavati J, Murray B, Nonyane BAS, Tandri H, Calkins H, James CA. Sharma A, et al. Circ Genom Precis Med. 2022 Jun;15(3):e003530. doi: 10.1161/CIRCGEN.121.003530. Epub 2022 May 17. Circ Genom Precis Med. 2022. PMID: 35579515
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a complex cardiomyopathy with autosomal dominant inheritance and age-related incomplete penetrance, characterized by a high risk of sudden cardiac death. ...Overall prevalence of VA among g …
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a complex cardiomyopathy with autosomal dominant …
Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia/cardiomyopathy: prevalence, patterns, and association with arrhythmias.
Zghaib T, Te Riele ASJM, James CA, Rastegar N, Murray B, Tichnell C, Halushka MK, Bluemke DA, Tandri H, Calkins H, Kamel IR, Zimmerman SL. Zghaib T, et al. J Cardiovasc Magn Reson. 2021 May 20;23(1):58. doi: 10.1186/s12968-020-00702-3. J Cardiovasc Magn Reson. 2021. PMID: 34011348 Free PMC article.
BACKGROUND: Left ventricular (LV) fibrofatty infiltration in arrhythmogenic right ventricular (RV) dysplasia/cardiomyopathy (ARVD/C) has been reported, however, detailed cardiovascular magnetic resonance (CMR) characteristics and association wit …
BACKGROUND: Left ventricular (LV) fibrofatty infiltration in arrhythmogenic right ventricular (RV) dysplasia …
Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
Woźniak O, Borowiec K, Konka M, Cicha-Mikołajczyk A, Przybylski A, Szumowski Ł, Hoffman P, Poślednik K, Biernacka EK. Woźniak O, et al. Heart. 2022 Jan;108(1):22-28. doi: 10.1136/heartjnl-2020-318415. Epub 2021 Mar 4. Heart. 2022. PMID: 33674353
OBJECTIVE: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with a risk of sudden cardiac death. ...CONCLUSIONS: Right ventricle dysfunction, age <40 years and a history of sustained ventricular tachycardia were predict …
OBJECTIVE: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with a risk of sudden cardiac death. .. …
131 results